Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis
Vitul Jain(International Centre for Genetic Engineering and Biotechnology), Amit Sharma(International Centre for Genetic Engineering and Biotechnology), Preeti Goel(International Centre for Genetic Engineering and Biotechnology), Karl Harlos(Centre for Human Genetics), Mohamed‐Ali Hakimi(Centre National de la Recherche Scientifique), M. Yogavel(International Centre for Genetic Engineering and Biotechnology), Haruhisa Kikuchi(Keio University), Rajiv S. Jumani(University of Vermont), Norimitsu Hariguchi(Otsuka (Japan)), Fabienne Tacchini‐Cottier(University of Lausanne), Yoshiteru Oshima(Tohoku University), Bastien Touquet(Centre National de la Recherche Scientifique), Makoto Matsumoto(Tottori University Hospital), Christopher D. Huston(University of Vermont)
Cited by 98
Related Papers
A Toll-like receptor recognizes bacterial DNA
|Nature|2000|6.4k
HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY
|The Lancet|1986|2.4k
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
|Immunity|1998|2k
Essential role of Stat6 in IL-4 signalling
|Nature|1996|1.6k
Targeted disruption of the mouse <i>Stat3</i> gene leads to early embryonic lethality
|Proceedings of the National Academy of Sciences|1997|1.3k